ZOLL HFMS may benefit patients who:

• Have an acute event for volume overload and have been effectively diuresed, are now stable, and will benefit from remote pulmonary fluid management to predictively prevent a recurrent hospitalization
• Have intermittent and/or poorly controlled dyspnea, orthopnea, edema, or other fluid overload-related symptoms
• Require GDMT pharmaceutical titration to control fluid overload

ZOLL HFMS may not benefit patients who:

• Are currently experiencing symptomatic volume overload and/or are considered “wet”
• Have their fluid status being actively monitored by an implanted device
• Do not meet indications for use⁺